| ¿µ¹® | five-year survival rate | ÇÑ±Û | ¿À³â»ýÁ¸À² |
|---|---|---|---|
| ¼³¸í | 1. µ¿ÀÏ Áúº´ÀÇ Áø´Ü ȤÀº Ä¡·á ÈÄ, 5³âÀÌ °æ°ú µÈ µÚÀÇ »ýÁ¸ÀÚ¼öÀÇ Ç¥Çö. 2. ¾ÏÀÇ Áø´Ü ¶Ç´Â Ä¡·á µÚ¿¡ °Ë»ç¸¦ ¹Ýº¹ÇÏ¿© 5³â µ¿¾È »ì¾Æ ÀÖ´Â »ç¶÷ÀÇ ¹éºÐÀ². Ä¡·á ÈÄ 5³â µ¿¾È »ýÁ¸Çϸé ÀÏ´Ü Ä¡À¯µÈ °ÍÀ¸·Î °£ÁÖÇÑ´Ù. |
||
| ¿µ¹® | red bone marrow | ÇÑ±Û | Àû»ö°ñ¼ö |
|---|---|---|---|
| ¼³¸í | ºÐÈÁßÀÇ °¥ºñ»À, ôÃß»À³ª ±× ¿ÜÀÇ ¸¹Àº ÀÛÀº »À¿¡ Àִ Ȱµ¿¼º °ñ¼öÀÌ´Ù. ÀûÇ÷±¸³ª °ú¸³¹éÇ÷±¸ÀÇ »ý»ê Àå¼ÒÀÌ´Ù. |
||
| ¿µ¹® | white blood cell(WBC), leukocyte | ÇÑ±Û | ¹éÇ÷±¸ |
|---|---|---|---|
| ¼³¸í | Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, ȤÀº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀÎ Çö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù. |
||
| ¿µ¹® | blood test | ÇÑ±Û | Ç÷¾×°Ë»ç |
|---|---|---|---|
| ¼³¸í | Ç÷¾×ÇüÀ̳ª Áúº´ À¯¹« µûÀ§¸¦ ¾Ë±â À§ÇÏ¿© ÇǸ¦ »Ì¾Æ ÇàÇÏ´Â °Ë»ç. ¸ö ÀüüÀÇ Àå±â³ª Á¶Á÷¿¡ º´ÅͰ¡ ÀÖÀ¸¸é ÀÌµé ¼ººÐ¿¡ º¯È°¡ ÀÖ°Ô µÇ¾î Áø´Ü¿¡ Å« µµ¿òÀ» ÁØ´Ù. |
||
| ¿µ¹® | blood clotting, blood coagulation | ÇÑ±Û | Ç÷¾×ÀÀ°í |
|---|---|---|---|
| ¼³¸í | »ç¶÷ÀÇ ¸ö¿¡ »óó°¡ ³ª¼ ÃâÇ÷ÀÌ ÀÖÀ» °æ¿ì¿¡ À̰ÍÀ» ¸·°í ÇǸ¦ ´õÀÌ»ó ³ªÁö ¾Ê°Ô ÇÏ´Â °ÍÀ» ÁöÇ÷À̶ó°í ÇÑ´Ù. ÁöÇ÷ÀÇ °úÁ¤¿¡´Â Å©°Ô µÎ °¡Áö ´Ü°è°¡ ÀÖ´Ù. ù¹øÂ° ´Ü°è´Â Ç÷¼ÒÆÇµéÀÌ »óó°¡ ³ª¼ ¼Õ»óµÈ Ç÷°üÀÇ ºÎÀ§¸¦ ¸·´Â °ÍÀÌ´Ù. ÀÌ·¸°Ô ÇÏ¸é ¿ì¼± Ç÷°üÀÇ ¼Õ»óºÎÀ§·Î ºÎÅÍ Çǰ¡ ³ª¿À´Â °ÍÀ» ¸·À» ¼ö°¡ ÀÖ´Ù. ´ÙÀ½ÀÇ ´Ü°è´Â »óó¸¦ ¸·°í ÀÖ´Â Ç÷¼ÒÆÇÀ§¿¡ ¿©·¯ °¡Áö ¹°ÁúµéÀÌ ÀÛ¿ëÇØ¼ ´õ¿í ´Ü´ÜÇÏ°Ô ÇÏ¿© »óó°¡ ³ Ç÷°ü¿¡¼ Çǰ¡ »õ´Â °ÍÀ» ¿µ±¸È÷ ¸·´Â °ÍÀÌ´Ù. ½±°Ô ¸»Çϸé Ç÷¼ÒÆÇÀº º®µ¹¿¡ ÇØ´çÇÏ´Â °ÍÀÌ°í µÎ¹øÂ° °úÁ¤¿¡ Âü¿©ÇÏ´Â ¹°ÁúµéÀº ½Ã¸àÆ®¿¡ ÇØ´çÇÏ´Â °ÍÀÌ´Ù. ÀÌ µÎ °úÁ¤ÀÌ ¿ÏÀüÇÒ °æ¿ì¿¡ ÁöÇ÷ÀÌ ¼øÁ¶·Ó°Ô ÀϾÙ. Ç÷¾×ÀÀ°í¶õ µÎ¹øÂ° ´Ü°è¸¦ ÁöĪÇÏ´Â ¸»·Î½á ¸Å¿ì º¹ÀâÇÑ ´Ü°è¸¦ °ÅÄ¡´Â ¹ÝÀÀÀ¸·Î ¸¶Áö¸· ´Ü°è´Â ¼¶À¯¼Ò¶ó´Â ¹°ÁúÀÌ ¸¸µé¾îÁ®¼ ÀÌ ¹°ÁúÀÌ Ç÷¼ÒÆÇ°ú ±× ¿ÜÀÇ ¼¼Æ÷¸¦ ´Ü´ÜÇÏ°Ô °íÁ¤½ÃÄÑ Çǰ¡ »óó³ Ç÷°üÀ¸·Î »õ´Â °ÍÀ» ¸·´Â´Ù. À̰ÍÀ» °¡Àå °£´ÜÈ÷ ¼³¸íÇÏÀÚ¸é Å©°Ô ´ÙÀ½°ú °°Àº 3°¡Áö ´Ü°è·Î ÀÌ·ç¾îÁø´Ù. ù¹øÂ° ´Ü°è´Â Ç÷°ü¼Õ»ó¿¡ ÀÇÇØ¼ ÇÁ·ÎÆ®·Òºó Ȱ¼ºÁ¦¶ó´Â °ÍÀÌ ¸¸µé¾îÁö´Â ´Ü°èÀÌ´Ù. µÎ¹øÂ° ´Ü°è´Â ÀÌ ÇÁ·ÎÆ®·Òºó Ȱ¼ºÁ¦¶ó´Â ¹°Áú¿¡ ÀÇÇØ¼ Ç÷¾×¼Ó¿¡ ÀÖ´Â ÇÁ·ÎÆ®·ÒºóÀ̶ó´Â ¹°ÁúÀÌ Æ®·ÒºóÀ̶ó´Â ¹°Áú·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù. ¼¼¹øÂ° ´Ü°è´Â Æ®·ÒºóÀ̶ó´Â ¹°Áú¿¡ ÀÇÇØ¼ ¼¶À¯¼Ò¿øÀ̶ó´Â ¹°ÁúÀÌ ¼¶À¯¼ÒÀ¸·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù. |
||
| DRBC | denaturated red blood cell; dog red blood cell; donkey red blood cell |
|---|---|
| RBC | red blood cell; red blood corpuscle; red blood count |
| RC | an electronic circuit containing a resistor and capacitor in series; radiocarpal; reaction center; r... |
| NRBC | National Rare Blood Club; normal red blood cell; nucleated red blood cell |
| ST | esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor... |
| RBC | Anti-red blood cell |
|---|---|
| SRBC | Anti-sheep red blood cell |
| HRBC | human red blood cell |
| IRBC | Infected red blood cell |
| NRBC | nucleated red blood cell |
| packed red blood cell | <haematology> Red blood cells collected from one individual that are packed into a small volume for transfusion into a patient. (16 Dec 1997) |
|---|---|
| red blood cell | <haematology> Cell specialised for oxygen transport, having a high concentration of haemoglobin in the cytoplasm (and little else). Biconcave, anucleate discs, 7nm diameter in mammals, nucleus contracted and chromatin condensed in other vertebrates. Acronym: RBC (18 Nov 1997) |
| red blood cell cast | A urinary cast composed of a matrix containing red cells in various stages of degeneration and visibility, characteristic of glomerular disease or renal parenchymal bleeding. Synonym: red cell cast. (05 Mar 2000) |
| red blood cell count | A normal value is 4.6-6.2 million RBC's per cubic millimetre of blood. This number can increase in cases of dehydration (fluid loss) or severe lung disease. Interestingly, red blood cell counts are much higher in those who live at high altitude, because of the increased demand for oxygen carrying capacity. (27 Sep 1997) |
| red blood cell indices | Laboratory measurements of red blood cell volume, size and haemoglobin concentration. These values are used to point to the specific cause for anaemia (iron deficiency, B12 deficiency, etc.) (27 Sep 1997) |
| cell survival | The span of viability of a cell characterised by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. (12 Dec 1998) |
| red cell adherence test | The diagnostic application of the immune adhesion phenomenon. Synonym: erythrocyte adherence test, immune adhesion test, red cell adherence test. (05 Mar 2000) |
| concentrated human red blood corpuscle | Corpuscle prepared from one or more preparations of whole human blood which are not more than 14 days old and each of which has already been directly matched with the blood of the intended recipient. (05 Mar 2000) |
| median survival | <statistics> Median means the middle value. An equal number of people live longer as die earlier than the median. (16 Dec 1997) |
| graft survival | <haematology> The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. (12 Dec 1998) |
| survival | 1. A living or continuing longer than, or beyond the existence of, another person, thing, or event; an outliving. 2. Any habit, usage, or belief, remaining from ancient times, the origin of which is often unknown, or imperfectly known. "The close bearing of the doctrine of survival on the study of manners and customs." (Tylor) Survival of the fittest. <biology> See Natural selection, under Natural. Origin: From Survive. Source: Websters Dictionary (01 Mar 1998) |
| survival analysis | A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. (12 Dec 1998) |
| survival rate | The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. (12 Dec 1998) |
| survival time | The period elapsing between the completion or institution of any procedure and death, the life-span of biologically or physically marked erythrocytes or other cells. (05 Mar 2000) |
| disease-free survival | Period after successful treatment in which there is no appearance of the symptoms or effects of the disease. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|